North America Medical Collagen Market Forecast 2022-2030

PUBLISHED: April 30, 2022

PAGES: 162 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The North America medical collagen market is set to record a CAGR of 5.90% during the forecast period, 2022-2030. The emerging needs in the healthcare sector of the region facilitate growth. Also, the region increasingly focuses on technological advancements. In this regard, collagen-based technology is used in medical devices, enabling opportunities for the key players to manufacture more medical devices.

MARKET INSIGHTS

Canada and the United States are analyzed for the North America medical collagen market growth evaluation. In Canada, the increasing awareness among the population regarding health and the benefits of collagen supplement consumption benefits market growth. These are rich in protein since they are derived from the bones and skins of chickens, pigs, and cows that are rich protein sources. In addition, collagen supplements aid in combating several health-related problems associated with hair, skin, and bones.

For instance, hair fall. Protein is necessary to maintain hair health. The protein deficiency leads to dry scalp and hair fall. Collagen, being a protein-rich source, helps tackle hair problems. As a result, the Canadian population is increasingly inclined to collagen consumption, given its benefits and properties.

Moreover, the presence of prominent market players and product launches contribute to market prospects. For instance, H&A Canada is a distributor that provides products like sweeteners and antioxidants. Also, Orora Skin Science is a beauty brand that introduced bioactive collagen serum and bioactive collagen cream to the market.

COMPETITIVE INSIGHTS

Some of the eminent market players are Lapi Gelatine, Italgel, Integra LifeSciences, Jellagen, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 44804

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING AWARENESS
- 3.1.2. GROWING DEMAND FROM MEDICAL DEVICES INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. RESTRICTED DEMANDS DUE TO ANIMAL-BASED PRODUCTS' USE
- 3.2.2. HEALTH-RELATED ISSUES

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON MEDICAL COLLAGEN MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. QUALITY
- 4.7.2. SIDE-EFFECTS
- 4.7.3. PRODUCT EFFECTIVENESS
- 4.7.4. PRICE
4.8. REGULATORY FRAMEWORK

5. MARKET BY SOURCE

5.1. BOVINE
5.2. PORCINE
5.3. OTHER SOURCES

6. MARKET BY PRODUCT

6.1. GELATINE
6.2. HYDROLYZED COLLAGEN
6.3. NATIVE COLLAGEN
6.4. OTHER PRODUCTS

7. MARKET BY APPLICATION

7.1. WOUND CARE
7.2. BONE GRAFTS
7.3. TISSUE SCAFFOLDS
7.4. CARTILAGE REPAIR
7.5. HAEMOSTATS
7.6. DIAGNOSTICS
7.7. VASCULAR GRAFTS
7.8. OTHER APPLICATIONS

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED STATES
  - 8.1.5.2. CANADA

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCTS LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. COLLAGEN MATRIX INC
- 9.2.2. CONNOILS LLC
- 9.2.3. DARLING INGREDIENTS INC
- 9.2.4. DSM
- 9.2.5. GELITA
- 9.2.6. INTEGRA LIFESCIENCES
- 9.2.7. ITALGEL
- 9.2.8. JELLAGEN
- 9.2.9. LAPI GELATINE
- 9.2.10. NIPPI INC
- 9.2.11. NITTA GELATIN
- 9.2.12. STRYKER
- 9.2.13. SYMATESE
- 9.2.14. TESSENDERLO
- 9.2.15. WEISHARDT

Product Code: 44804

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MEDICAL COLLAGEN
TABLE 2: SOME MEDICAL APPLICATIONS OF COLLAGEN
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY SOURCE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY SOURCE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: LEADING PLAYERS OPERATING IN NORTH AMERICA MEDICAL COLLAGEN MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: NORTH AMERICA MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY SOURCE, IN 2021
FIGURE 8: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 12: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 17: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2030 (IN $ MILLION)
FIGURE 20: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2030 (IN $ MILLION)
FIGURE 21: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY HAEMOSTATS, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 25: NORTH AMERICA MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 26: UNITED STATES MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: CANADA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)